Navigation Links
JHP Pharmaceuticals to Produce Lyophilized Biologic for International Late-Phase Clinical Trials
Date:9/19/2012

PARSIPPANY, N.J., Sept. 19, 2012 /PRNewswire/ -- JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed pharmaceutical company to produce supplies of a lyophilized biologic for international, late-phase clinical trials.

Stuart Hinchen president and CEO of JHP stated, "We know that customers want to seamlessly progress from clinical batch production to product launch and then commercialization.  JHP's established infrastructure and expertise transitioning products from clinical to commercial supply are recognized by customers looking for long-term reliability and continuity when selecting a contract manufacturing organization.  Additionally, our cGMP compliance record and experienced staff allows customers to focus on their pressing business needs with confidence."

JHP has successfully supported launches of several products in US and international markets and manufactures products for sale in 86 countries.  JHP's Rochester, Michigan manufacturing site's 25-year history in contract manufacturing is a result of a solid cGMP compliance record, a quality-driven experienced staff and a customer-centric approach.

About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile products including biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse.  The production facility utilizes three high-speed filling lines, a clinical filling line and four lyophilizers.  The site also includes separate facilities for chemistry, sterility testing, and analytical methods development. 

JHP has the capability to manufacture small-scale clinical through large-scale commercial products.  JHP employs more than 370 staff in the USA in its manufacturing, product development, regulatory, sales and marketing and corporate areas.  For more information, please visit www.jhppharma.com.

CONTACT:
Dan Leone
973.658.3559

Bill Conway
877.906.7556
jhpcontractservices@jhppharma.com

 


'/>"/>
SOURCE JHP Pharmaceuticals, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 FinancialBuzz.com News ... According to ... was worth an estimated $6.6 billion in 2016, and is projected ... or reaching more than $24 billion by 2025. The medical cannabis ... growing from $4.7 billion in 2016, to an estimated $13.3 billion ...
(Date:3/22/2017)... 2017 EMD Serono, the biopharmaceutical business of Merck ... and Canada , today announced two new ... session at the 65 th Annual Pacific Coast Reproductive ... on March 24 th .   The results ... collected from July 2009 to December 2015 containing data from ...
(Date:3/22/2017)... MarketNewsUpdates.com News Commentary  ... As ... oil continues to rise in popularity with consumers, Cannabis ... enhancing production through acquiring innovative assets and other plant ... include: Future Farm Technologies Inc (OTC: FFRMF) (CSE: FFT.CN), mCig, ...
Breaking Medicine Technology:
(Date:3/22/2017)... Bolton, MA San Antonio, TX (PRWEB) , ... ... ... audited and ISO certified medical imaging core lab with extensive therapeutic experience and ... awarded a multi-year phase II immuno-oncology clinical trial for the treatment of non-small ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... protection assistance and financial consultations to families and business owners in the greater ... for the local American Cancer Society Relay For Life event. , Each year, ...
(Date:3/22/2017)... TX (PRWEB) , ... March 22, 2017 , ... ... insurance consultation, financial planning, and related services to communities across eastern Texas, is ... the goal of providing meals to hungry children and adults. , Consistently ...
(Date:3/22/2017)... ... March 22, 2017 , ... Schneider Insurance and Financial, ... business owners throughout the Yellowstone Valley region, is launching a charity event aimed at ... botanical garden in all of Montana State, and is home to a broad variety ...
(Date:3/22/2017)... ... ... Chris Humphrey Insurance Agency, a North Carolina firm offering asset protection services ... is initiating a charity event to raise support for five year old Dillyn, a ... a Friday evening in September 2014. At the time, Dillyn was only four years ...
Breaking Medicine News(10 mins):